[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341188-105":59,"doc-detail-341188-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","longitudinal-assessment-of-real-world-patient-adherence-a-12-month-electronic-patient-reported-outcomes-follow-up-of-women-with-early-breast-cancer-undergoing-treatment-abstract","Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment - Abstract","","Electronic patient-reported outcomes (ePROs) are intended to capture patients’ health status and quality of life in routine oncology care, yet real-world use and adherence remain insufficiently characterized. This study evaluated adherence to ePRO follow-up among women with invasive breast cancer and ductal carcinoma in situ (DCIS), and assessed patient characteristics related to longitudinal non-adherence. A prospective PRO routine program required baseline completion and consent to email-based follow-up during the first 12 months after treatment initiation. Results quantified baseline and follow-up response rates and identified factors associated with non-adherence, including age, comorbidities, chemotherapy use, and baseline physical functioning. Findings indicate moderate adherence over 12 months and suggest targeted strategies to improve engagement.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/longitudinal-assessment-of-real-world-patient-adherence-a-12-month-electronic-patient-reported-outcomes-follow-up-of-women-with-early-breast-cancer-undergoing-treatment-abstract/341188/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/longitudinal-assessment-of-real-world-patient-adherence-a-12-month-electronic-patient-reported-outcomes-follow-up-of-women-with-early-breast-cancer-undergoing-treatment-abstract/341188.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of electronic patient-reported outcomes (ePROs) in this study?","Question",{"text":112,"@type":113},"ePROs are used to assess patients’ health status and quality of life and to support patient care by enabling symptom monitoring and professional interpretation. The study focuses on how patients adhere to ePRO follow-up in routine practice.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was adherence to ePROs measured over the first 12 months?",{"text":117,"@type":113},"Patients completed ePRO assessments and consented to email-based follow-up in the first 12 months after therapy started. Adherence was quantified using completion and response rates across the scheduled follow-up assessments.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with longitudinal non-adherence?",{"text":121,"@type":113},"Longitudinal non-adherence was associated with younger age, a higher number of comorbidities, no chemotherapy, and a low baseline physical functioning score on the EORTC QLQ-C30.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341188,1790181836,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Supportive Care in Cancer (2024) 32:344  \n[https://doi.org/10.1007/s00520-024-08547-7](https://doi.org/10.1007/s00520-024-08547-7)  \nLongitudinal assessment of real‑world patient adherence: a 12‑month electronic patient‑reported outcomes follow‑up of women with early breast cancer undergoing treatment  \nPimrapat Gebert1,2 · Anna Maria Hage3 · Jens‑Uwe Blohmer3 · Robert Roehle1,2 · Maria Margarete Karsten3  \nReceived: 10 January 2024 / Accepted: 3 May 2024 / Published online: 14 May 2024 © The Author(s) 2024  \nAbstract  \nBackground Electronic patient-reported outcomes (ePROs) assess patients’ health status and quality of life, improving patient care and treatment effects, yet little is known about their use and adherence in routine patient care.  \nAims We evaluated the adherence of invasive breast cancer and ductal carcinoma in situ (DCIS) patients to ePROs follow-up and whether specific patient characteristics are related to longitudinal non-adherence.  \nMethods Since November 2016, the Breast Center at Charité – Universitätsmedizin Berlin has implemented an ongoing prospective PRO routine program, requiring patients to complete ePROs assessments and consent to email-based follow-up in the first 12 months after therapy starts. Frequencies and summary statistics are presented. Multiple logistic regression models were performed to determine an association between patient characteristics and non-adherence.  \nResults Out of 578 patients, 239 patients (41.3%, 95%CI: 37.3–45.5%) completed baseline assessment and all five ePROs follow-up during the first 12 months after therapy. On average, above 70% of those patients responded to the ePROs follow-up assessment. Adherence to the ePROs follow-up was higher during the COVID-19 pandemic than in the time periods before (47.4%(111/234) vs. 33.6%(71/211)). Factors associated with longitudinal non-adherence were younger age, a higher number of comorbidities, no chemotherapy, and a low physical functioning score in the EORTC QLQ-C30 at baseline.  \nConclusions The study reveals moderate adherence to 12-month ePROs follow-up assessments in invasive early breast cancer and DCIS patients, with response rates ranging from 60 to 80%. Emphasizing the benefits for young patients and those with high disease burdens might further increase adherence.  \nKeywords Oncology · Web-based questionnaire · Return rate · Compliance · Early Breast cancer  \nIntroduction  \nThe utilization of digital health technologies on smartphones, tablets, and computers for the purposes of symptom monitoring and assessing quality of life throughout the follow-up period has increased rapidly [1]. In oncological care, electronic patient-reported outcomes (ePROs) have been extensively  \n* Maria Margarete Karsten [maria-margarete.karsten@charite.de](maria-margarete.karsten@charite.de)  \n1 Berlin Institute of Health at Charité –Universitätsmedizin Berlin, Berlin, Germany  \n2 Institute of Biometry and Clinical Epidemiology, Charité – Universitätsmedizin Berlin, Berlin, Germany  \n3 Department of Gynecology With Breast Center, Charité – Universitätsmedizin Berlin, Berlin, Germany  \nstudied to enable patients to self-report symptoms and quality of life, as well as to monitor patients during oncological treatment [2–6] . It is important to note that the ePROs are valuable resources when reviewed and used by healthcare professionals, highlighting the crucial role of professional interpretation and utilization. Patient-reported outcomes (PROs) refer to any report of a patient’s health status that comes directly from the patient without interpretation by a clinician or anyone else [7] . The European Organization for Research and Treatment of Cancer’s Quality of Life Questionnaire (EORTC QLQ-C30)  \n[8] is one of the widely used instruments assessing PROs in oncological research. Numerous studies have demonstrated that continuously monitoring ePROs not only enhances the accuracy of symptom assessment and functional status of patients [2, 9, 1","cbCaiq3LhHVRYs2O","https://ap.wps.com/l/cbCaiq3LhHVRYs2O","pdf",1642445,11,"English","# Abstract\n## Background\n## Aims\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Digital health and ePROs in oncology\n## Adherence rates in trials vs routine care","[{\"question\":\"What is the purpose of electronic patient-reported outcomes (ePROs) in this study?\",\"answer\":\"ePROs are used to assess patients’ health status and quality of life and to support patient care by enabling symptom monitoring and professional interpretation. The study focuses on how patients adhere to ePRO follow-up in routine practice.\"},{\"question\":\"How was adherence to ePROs measured over the first 12 months?\",\"answer\":\"Patients completed ePRO assessments and consented to email-based follow-up in the first 12 months after therapy started. Adherence was quantified using completion and response rates across the scheduled follow-up assessments.\"},{\"question\":\"Which factors were associated with longitudinal non-adherence?\",\"answer\":\"Longitudinal non-adherence was associated with younger age, a higher number of comorbidities, no chemotherapy, and a low baseline physical functioning score on the EORTC QLQ-C30.\"}]","Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment - Abstract | PDF",1790040801,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1c32b00c8385799934fdac2be97b9d2.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fdd690e15f1aa128a0f19570333f91d.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7373b6e300a2fdbe098ac6fe1236eba0.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f49988b30e77e92f44b38349cde796c8.webp",980,1301]